Pembrolizumab,Pemetrexed,Cisplatin
merck
['pembro']
3. 440 pm patients participated. arms were well balanced. mos was 17.3 months for cp-pembro vs 16.1 months for cp (hr 0.79 95%ci 0.64-0.98; p=0.0324). #asco23 #cancertreatment 
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer